Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Intravenous Efgartigimod for the Treatment of Primary Immune Thrombocytopenia in Adults: A Planned, Phase 3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Arm Study with Open-Label Period (ADVANCE NEXT)

Hanny Al-Samkari, Vickie McDonald, Monica Carpenedo, Francesco Zaja, Nichola Cooper, Spero Cataland, Michael W Drazer, Yoshitaka Miyakawa, Marc Michel, Jaume Ayguasanosa, Janki Brahmbhatt, Lan Lan, Filip Matthijssens, Catherine M. Broome, Waleed Ghanima

Blood (2024) 144 (Supplement 1): 2570.1.

https://doi.org/10.1182/blood-2024-194816

Published: 2024

Journal Articles

Targeting Menin in T-Lineage Acute Lymphoblastic Leukemia

Kathryn Kimi Shimamoto, Arda Arda Karaoglu, Zachary Chan, Giorgia Giordano, Bartholomew Eisfelder, Jason Xiaojun Cheng, Hamed Youshanlouei, Syed Shah, Anand Ashwin Patel, Adam S. Duvall, Francis Burrows, Linda Kessler, Michael W Drazer, Olatoyosi Odenike, Michael J. Thirman, Wendy Stock, Caner Saygin

Blood (2024) 144 (Supplement 1): 1452.

https://doi.org/10.1182/blood-2024-201741

Published: 2024

Journal Articles

Interim Results of a Phase II Study Investigating Dasatinib and Inotuzumab Ozogamicin-Based Induction for Newly-Diagnosed Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Anand Ashwin Patel, Adam S. Duvall, Caner Saygin, Howard Weiner, Emily Dworkin, Afsheen Noorani, Jamie Matthews, Rafael Madero Marroquin, Michael W Drazer, Mariam T. Nawas, Gregory W Roloff, Satyajit Kosuri, Michael J. Thirman, Richard A. Larson, Olatoyosi Odenike, Theodore Karrison, Wendy Stock

Blood (2024) 144 (Supplement 1): 1432.

https://doi.org/10.1182/blood-2024-193442

Published: 2024

Journal Articles

Clinical and Molecular Characterization of TP53-Mutant Acute Lymphoblastic Leukemia

Blood (2024) 144 (Supplement 1): 1425.

https://doi.org/10.1182/blood-2024-212213

Published: 2024

Journal Articles

Prevalence and Clinical Implications of Germline Variants in Multiple Myeloma Patients

Tadeusz Kubicki, Kaina Millan, Anna Pula, Henry Raeder, Quinn Hauck, Manoj Bhagwat, Jude Barton, Eyitayo Awe, Soma Das, Daniela Del Gaudio, Sulin Wu, Frank Wen, Jennifer H Cooperrider, Benjamin A Derman, Andrzej J Jakubowiak, Michael W Drazer

Blood (2024) 144 (Supplement 1): 3335.

https://doi.org/10.1182/blood-2024-207445

Published: 2024

Journal Articles

Expanding the Morphologic Spectrum of ANKRD26-Related Thrombocytopenia-2: A Case Series

Lara Wahlster, Jared H. Rowe, Nina Weichert-Leahey, Robert Grant Rowe, Karyn Brundige, Lucy Godley, Jason Xiaojun Cheng, Michael W Drazer, Christopher R. Reilly, Alan D. Michelson, Alan B. Cantor, Akiko Shimamura, Jacob R. Bledsoe

Blood (2024) 144 (Supplement 1): 5708.

https://doi.org/10.1182/blood-2024-208018

Published: 2024

Journal Articles

Outcomes of BCR::ABL1 -like B-Lineage Acute Lymphoblastic Leukemia in the Era of Novel Therapies

Blood (2024) 144 (Supplement 1): 5918.

https://doi.org/10.1182/blood-2024-208069

Published: 2024

Journal Articles

Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition

Jiarna R. Zerella, Claire C. Homan, Peer Arts, Xuzhu Lin, Sam J. Spinelli, Parvathy Venugopal, Milena Babic, Peter J. Brautigan, Lynda Truong, Luis Arriola-Martinez, Sarah Moore, Rachel Hollins, Wendy T. Parker, Hung Nguyen, Karin S. Kassahn, Susan Branford, Simone Feurstein, Lise Larcher, Flore Sicre de Fontbrune, Serwet Demirdas, Sonja de Munnik, Hélène Antoine-Poirel, Benedicte Brichard, Sahar Mansour, Kristiana Gordon, Marcin W. Wlodarski, Ashwin Koppayi, Sara Dobbins, Pim G. N. J. Mutsaers, Kim E. Nichols, Ninad Oak, Desiree DeMille, Rong Mao, Ali Crawford, Julie McCarrier, Donald Basel, Josue Flores-Daboub, Michael W. Drazer, Kerry Phillips, Nicola K. Poplawski, Graeme M. Birdsey, Daniela Pirri, Pia Ostergaard, Annet Simons, Lucy A. Godley, David M. Ross, Devendra K. Hiwase, Jean Soulier, Anna L. Brown, Catherine L. Carmichael, Hamish S. Scott, Christopher N. Hahn

Blood (2024) 144 (17): 1765–1780.

https://doi.org/10.1182/blood.2024024607

Published: 2024

Includes: Supplemental data

Journal Articles

ERG Is a New Predisposition Gene for Bone Marrow Failure and Hematological Malignancy

Blood (2023) 142 (Supplement 2): LBA-6.

https://doi.org/10.1182/blood-2023-191986

Published: 2023

Journal Articles

Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages

Blood (2022) 140 (24): 2533–2548.

https://doi.org/10.1182/blood.2022015790

Published: 2022

Includes: Supplemental data

Journal Articles

Stagnation in Quality of Next-Generation Sequencing Assays for the Diagnosis of Hereditary Hematopoietic Malignancies

Gregory W. Roloff, Reid Shaw, Timothy E. O'Connor, Michael W. Drazer

Blood (2022) 140 (Supplement 1): 5090–5091.

https://doi.org/10.1182/blood-2022-164623

Published: 2022

Journal Articles

Somatic Mutational Landscape of Hereditary Hematopoietic Malignancies Associated with Germline Variants in RUNX1 , GATA2 and DDX41

Anna L. Brown, Claire Homan, Michael W. Drazer, Kai Yu, David Lawrence, Jinghua Feng, Luis Arriola-Martinez, Matthew Pozsgai, Kelsey McNeely, Thuong Ha, Parvathy Venugopal, Peer Arts, Sarah King-Smith, Jesse JC Cheah, Mark Armstrong, Csaba Bödör, Paul Wang, Alan B. Cantor, Mario Cazzola, Erin Degelman, Courtney D. DiNardo, Nicolas Duployez, Remi Favier, Stefan Fröhling, Ana Rio-Machin, Jeffery M. Klco, Alwin Krämer, Mineo Kurokawa, Joanne Lee, Luca Malcovati, Neil V Morgan, Georges Natsoulis, Carolyn Owen, Keyur P. Patel, Claude Preudhomme, Hana Raslova, Hugh Young Rienhoff, Jr., Tim Ripperger, Rachael Schulte, Kiran Tawana, Elvira Deolinda Rodrigues Pereira Velloso, Benedict Yan, Raman Sood, Amy Hsu, Steven M. Holland, Kerry Phillips, Nicola Poplawski, Milena Babic, Erika M Kwon Kim, Andrew H. Wei, Cecily Forsyth, Helen Mar Fan, Ian D Lewis, Julian Cooney, Rachel Susman, Lucy C Fox, Piers Blombery, Deepak Singhal, Devendra Hiwase, Andreas W Schreiber, Christopher N Hahn, Hamish S Scott, Paul P. Liu, Lucy A. Godley

Blood (2022) 140 (Supplement 1): 4030–4033.

https://doi.org/10.1182/blood-2022-167600

Published: 2022

Journal Articles

Clinical and Molecular Response Assessment of AML Harboring Non-Canonical FLT3 p.N676K Driver Mutations to FLT3 Inhibitor Therapies

Gregory W. Roloff, Andrew S. Artz, Wendy Stock, Olatoyosi Odenike, Emily Dworkin, Geoffrey D. Wool, Carrie Fitzpatrick, Jeremy Segal, Peng Wang, Michael W. Drazer

Blood (2022) 140 (Supplement 1): 11727–11728.

https://doi.org/10.1182/blood-2022-166298

Published: 2022

Journal Articles

Deleterious Germline Variants Are Present in Patients with Myelodysplastic Syndrome of All Ages Treated with Related Allogeneic Stem Cell Transplantation

Simone K. Feurstein, Amy M. Trottier, Noel Estrada-Merly, Matthew Pozsgai, Kelsey McNeely, Michael W. Drazer, Bart L. Scott, Betul Oran, Coleman Lindsley, Ryotaro Nakamura, Ronald M. Sobecks, Soyoung Kim, Stephen R. Spellman, Wael Saber, Lucy A. Godley

Blood (2021) 138 (Supplement 1): 320.

https://doi.org/10.1182/blood-2021-148866

Published: 2021

Journal Articles

Therapy-Related Myeloid Neoplasms in 108 Patients Following Radiation Therapy Only

Anand Ashwin Patel, MD, Alexandra E Rojek, MD, Howard Weiner, Michael W. Drazer, MD, Lucy A. Godley, Michelle M. Le Beau, PhD, Richard A. Larson, MD

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-134433

Published: 2020

NARROW

Intravenous Efgartigimod for the Treatment of Primary Immune Thrombocytopenia in Adults: A Planned, Phase 3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Arm Study with Open-Label Period (ADVANCE NEXT)

Targeting Menin in T-Lineage Acute Lymphoblastic Leukemia

Interim Results of a Phase II Study Investigating Dasatinib and Inotuzumab Ozogamicin-Based Induction for Newly-Diagnosed Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Clinical and Molecular Characterization of TP53-Mutant Acute Lymphoblastic Leukemia

Prevalence and Clinical Implications of Germline Variants in Multiple Myeloma Patients

Expanding the Morphologic Spectrum of ANKRD26-Related Thrombocytopenia-2: A Case Series

Outcomes of BCR::ABL1 -like B-Lineage Acute Lymphoblastic Leukemia in the Era of Novel Therapies

Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition

ERG Is a New Predisposition Gene for Bone Marrow Failure and Hematological Malignancy

Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages

Stagnation in Quality of Next-Generation Sequencing Assays for the Diagnosis of Hereditary Hematopoietic Malignancies

Somatic Mutational Landscape of Hereditary Hematopoietic Malignancies Associated with Germline Variants in RUNX1 , GATA2 and DDX41

Clinical and Molecular Response Assessment of AML Harboring Non-Canonical FLT3 p.N676K Driver Mutations to FLT3 Inhibitor Therapies

Deleterious Germline Variants Are Present in Patients with Myelodysplastic Syndrome of All Ages Treated with Related Allogeneic Stem Cell Transplantation

Therapy-Related Myeloid Neoplasms in 108 Patients Following Radiation Therapy Only

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only